The designs of a new breathing aid developed by engineers at UCL and Formula One working with clinicians at UCLH have been made freely available to support the global response to Covid-19.
The UCL-Ventura breathing aid, a Continuous Positive Airway Pressure (CPAP) device, helps Covid-19 patients with lung infections to breathe more easily, when an oxygen mask alone is insufficient.
CPAP devices are in short supply in UK hospitals, so engineers at UCL and Mercedes-AMG HPP worked round-the-clock to reverse engineer a device that could be manufactured rapidly by the thousands.
The breathing aid was produced within a rapid timeframe – it took fewer than 100 hours from the initial meeting to production of the first device. Mark II of the device, which has reduced oxygen consumption by up to 70% compared to the Mark I model, received MHRA regulatory approval last week.